We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $21.7B
1-Year Est. Return 30.58%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+30.58%
3 Year Est. Return
+82.67%
5 Year Est. Return
+103.42%
10 Year Est. Return
+340.42%
AUM
$6.24B
AUM Growth
+$139M
Cap. Flow
+$46.3M
Cap. Flow %
0.74%
Top 10 Hldgs %
26.92%
Holding
404
New
21
Increased
154
Reduced
178
Closed
12

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$55.6M
2
OKE icon
Oneok
OKE
+$38.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$38.1M
4
MCD icon
McDonald's
MCD
+$33.4M
5
T icon
AT&T
T
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Technology 15.44%
3 Consumer Staples 14.37%
4 Industrials 12.52%
5 Energy 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$334B
$340M 5.44%
4,214,551
-36,491
-0.9% -$2.88M
JNJ icon
2
Johnson & Johnson
JNJ
$646B
$198M 3.17%
2,015,235
-15,883
-0.8% -$1.47M
USB icon
3
US Bancorp
USB
$97.3B
$181M 2.89%
4,213,892
+63,521
+2% +$2.61M
MSFT icon
4
Microsoft
MSFT
$3.81T
$150M 2.4%
3,660,802
+18,803
+0.5% +$706K
EMR icon
5
Emerson Electric
EMR
$86.6B
$144M 2.32%
2,162,836
-2,638
-0.1% -$174K
CVX icon
6
Chevron
CVX
$396B
$139M 2.23%
1,171,393
+5,380
+0.5% +$626K
NVS icon
7
Novartis
NVS
$292B
$139M 2.23%
1,827,448
-3,466
-0.2% -$253K
GE icon
8
GE Aerospace
GE
$355B
$133M 2.14%
1,075,569
+26,859
+3% +$3.32M
QCOM icon
9
Qualcomm
QCOM
$175B
$132M 2.11%
1,668,280
+21,178
+1% +$1.59M
MCD icon
10
McDonald's
MCD
$188B
$123M 1.98%
1,258,525
-349,694
-22% -$33.4M
KO icon
11
Coca-Cola
KO
$386B
$117M 1.88%
3,029,520
-7,970
-0.3% -$308K
OKE icon
12
Oneok
OKE
$59.7B
$116M 1.87%
1,965,305
-663,736
-25% -$38.8M
CFR icon
13
Cullen/Frost Bankers
CFR
$10B
$116M 1.86%
1,500,037
+24,070
+2% +$1.8M
WMB icon
14
Williams Companies
WMB
$90.2B
$111M 1.79%
2,745,502
-457,692
-14% -$18.5M
MRK icon
15
Merck
MRK
$366B
$109M 1.74%
2,007,010
+349,335
+21% +$18.1M
CSCO icon
16
Cisco
CSCO
$433B
$108M 1.73%
4,825,114
-122,454
-2% -$2.71M
ABBV icon
17
AbbVie
ABBV
$451B
$106M 1.7%
2,061,411
+15,657
+0.8% +$791K
MMM icon
18
3M
MMM
$89.9B
$104M 1.66%
913,684
+747,418
+450% +$83M
KMB icon
19
Kimberly-Clark
KMB
$36.4B
$93.8M 1.5%
887,255
-59,282
-6% -$6.14M
INTC icon
20
Intel
INTC
$473B
$90.7M 1.45%
3,514,791
-2,225,871
-39% -$55.6M
BAX icon
21
Baxter International
BAX
$13.5B
$84.8M 1.36%
2,121,320
+785,656
+59% +$29.4M
PM icon
22
Philip Morris
PM
$299B
$83.3M 1.34%
1,018,069
-55,253
-5% -$4.46M
XOM icon
23
ExxonMobil
XOM
$644B
$83.1M 1.33%
850,910
-17,300
-2% -$1.65M
AAPL icon
24
Apple
AAPL
$4.67T
$82.7M 1.33%
4,315,612
+84,504
+2% +$1.61M
KRFT
25
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$82.5M 1.32%
1,470,014
+40,458
+3% +$2.2M

Similar funds

Bahl & Gaynor's Q1 2014 Portfolio in Review

As of Q1 2014, Bahl & Gaynor held 404 positions worth $6.24B, up 2.3% from $6.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q1 2014 filing shows 21 new, 154 increased, 178 reduced and 12 closed positions. Its largest new stake was Cencora: 276,922 shares worth $18.2M. The largest sale was Intel, an estimated $55.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Staples.

  • Bahl & Gaynor's largest Q1 2014 buy was Cencora: 276,922 shares worth $18.2M.
  • Bahl & Gaynor added most to 3M in Q1 2014, an estimated $83M increase.
  • Bahl & Gaynor's biggest Q1 2014 reduction was Intel, cutting an estimated $55.6M.
  • Bahl & Gaynor fully exited Atrion Corp in Q1 2014, selling an estimated $478K.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.24B portfolio in Q1 2014.
  • Bahl & Gaynor opened 21 new positions and closed 12 in Q1 2014.
  • Bahl & Gaynor's portfolio value rose 2.3% quarter-over-quarter to $6.24B.

Based on Bahl & Gaynor's 13F filing for Q1 2014, filed 20 May 2014.